Aurinia Pharmaceuticals Inc (AUPH)
11.75
+0.39 (+3.43%)
USD |
NASDAQ |
May 26, 10:21
Aurinia Pharmaceuticals Price to Book Value: 3.717 for May 26, 2022
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 25, 2022 | 3.593 |
| May 24, 2022 | 3.577 |
| May 23, 2022 | 3.745 |
| May 20, 2022 | 3.811 |
| May 19, 2022 | 3.685 |
| May 18, 2022 | 3.546 |
| May 17, 2022 | 3.622 |
| May 16, 2022 | 3.476 |
| May 13, 2022 | 3.533 |
| May 12, 2022 | 3.128 |
| May 11, 2022 | 3.030 |
| May 10, 2022 | 3.565 |
| May 09, 2022 | 2.829 |
| May 06, 2022 | 3.214 |
| May 05, 2022 | 3.432 |
| May 04, 2022 | 3.596 |
| May 03, 2022 | 3.517 |
| May 02, 2022 | 3.444 |
| April 29, 2022 | 3.255 |
| April 28, 2022 | 3.328 |
| April 27, 2022 | 3.416 |
| April 26, 2022 | 3.457 |
| April 25, 2022 | 3.603 |
| April 22, 2022 | 3.422 |
| April 21, 2022 | 3.464 |
| Date | Value |
|---|---|
| April 20, 2022 | 3.647 |
| April 19, 2022 | 3.527 |
| April 18, 2022 | 3.574 |
| April 14, 2022 | 3.748 |
| April 13, 2022 | 3.884 |
| April 12, 2022 | 3.669 |
| April 11, 2022 | 3.770 |
| April 08, 2022 | 3.789 |
| April 07, 2022 | 3.834 |
| April 06, 2022 | 3.818 |
| April 05, 2022 | 3.830 |
| April 04, 2022 | 3.970 |
| April 01, 2022 | 3.982 |
| March 31, 2022 | 3.916 |
| March 30, 2022 | 3.663 |
| March 29, 2022 | 3.752 |
| March 28, 2022 | 3.652 |
| March 25, 2022 | 3.681 |
| March 24, 2022 | 3.785 |
| March 23, 2022 | 3.699 |
| March 22, 2022 | 3.696 |
| March 21, 2022 | 3.483 |
| March 18, 2022 | 3.533 |
| March 17, 2022 | 3.436 |
| March 16, 2022 | 3.294 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.271
Minimum
Dec 29 2017
18.88
Maximum
Dec 26 2019
4.941
Average
4.316
Median
Price to Book Value Benchmarks
| Edesa Biotech Inc | 1.598 |
| Lexaria Bioscience Corp | 1.044 |
| Liminal Biosciences Inc | 0.4642 |
| Xenon Pharmaceuticals Inc | 2.622 |
| ESSA Pharma Inc | 1.397 |
Price to Book Value Related Metrics
| PS Ratio | 23.55 |
| PEG Ratio | -0.3783 |
| Price | 11.75 |
| Earnings Yield | -10.89% |
| Market Cap | 1.665B |
| PEGY Ratio | -0.3783 |